We are live on ! Find out more
YARW icon

Yarrow Bioscience

50 hedge funds and large institutions have $213M invested in Yarrow Bioscience in 2026 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,127% more capital inflows, than outflows

Capital inflows: $316M | Capital outflows: $3.42M

400% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 3

310.57% more ownership

Funds ownership: 43.52% → 354.09% (+311%)

36% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 22

19% more funds holding

Funds holding: 42 → 50 (+8)

Holders
50
Holders Change
+8
Holders Change %
+19.05%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
30
Increased
15
Reduced
3
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

YARW Hedge Fund Activity: Q3 2026 in Review

50 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Yarrow Bioscience (YARW) for Q3 2026, worth a combined $213M — up 2,154% from $9.44M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new YARW positions and 22 closed out — a net gain of 8 holders — while 15 added to existing stakes and 3 trimmed.

The largest buyer was Logos Global Management, opening a new position worth an estimated $35M. The largest seller was Shay Capital, exiting entirely with an estimated $948K sold.

  • 50 institutional investors held Yarrow Bioscience (YARW) as of Q3 2026, up from 42 in Q2 2026.
  • Funds reported $213M of Yarrow Bioscience stock for Q3 2026, up 2,154% quarter-over-quarter.
  • 30 funds opened new Yarrow Bioscience positions in Q3 2026 and 22 closed out, a net change of +8 holders.
  • The largest Yarrow Bioscience buyer in Q3 2026 was Logos Global Management, an estimated $35M added.
  • The largest Yarrow Bioscience seller in Q3 2026 was Shay Capital, an estimated $948K sold.

Based on aggregated 13F filings for Q3 2026.